免疫细胞治疗的新兴领域
Evan W Weber1, Marcela V Maus2, Crystal L Mackall3
1Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Cell
|April 4, 2020
概括
免疫细胞疗法是先进的"活药", 对癌症和传染病具有长期益处. 工程学的进步提高了它们的功效,安全性和治疗各种疾病的潜力.
科学领域:
- 免疫学
- 生物技术
- 细胞疗法
背景情况:
- 细胞疗法代表了一种新的药物开发模式,免疫细胞疗法在瘤学和传染病方面取得了显著的临床成功.
- 这些"活疗法"具有独特的特性,比如自我调节和单次使用后长时间的治疗效果,使其与传统药物不同.
研究的目的:
- 总结目前癌症,传染病和自身免疫性疾病的免疫细胞疗法.
- 讨论细胞工程中的新兴进展,旨在提高这些疗法的有效性和安全性.
主要方法:
- 对免疫细胞治疗的最新科学文献和临床试验数据的审查.
- 分析基础免疫学,基因工程,基因编辑和合成生物学方面的进展.
主要成果:
- 免疫细胞疗法在治疗癌症和传染病方面具有明显的临床益处.
- 目前正在进行的细胞工程研究正在扩大这些活体药物的能力和治疗应用.
结论:
- 免疫细胞疗法是一个快速发展的领域,具有治疗各种疾病的巨大潜力.
- 对于克服现有挑战和扩大治疗可能性, 细胞工程的持续创新至关重要.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cytotoxic T Cells-mediated Immune Response
6.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
Cell-mediated Immune Responses
83.0K
Overview
83.0K
Cells of the Adaptive Immune Response
8.2K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
8.2K
Regulation of Hematopoietic Stem Cells
3.8K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.8K


